miR-200 members were found to regulate BMI1 expression in breast cancer tumor initiating cells and also to suppress epithelial mesenchymal transition (EMT) through inhibition of zinc-finger E-box binding homeobox (ZEB)1 and ZEB2 and subsequent modulation of BC cell migration (41–43). The gene discussed is ZEB2; the disease is breast cancer.